GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
NCT04121273
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
CAR-T cell immunotherapy
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School